Cargando…

Neurodegenerative processes in Huntington's disease

Huntington's disease (HD) is a complex and severe disorder characterized by the gradual and the progressive loss of neurons, predominantly in the striatum, which leads to the typical motor and cognitive impairments associated with this pathology. HD is caused by a highly polymorphic CAG trinucl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bano, D, Zanetti, F, Mende, Y, Nicotera, P
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2011
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3223696/ https://www.ncbi.nlm.nih.gov/pubmed/22071633 http://dx.doi.org/10.1038/cddis.2011.112

Ejemplares similares

Mitochondrial Bioenergy in Neurodegenerative Disease: Huntington and Parkinson
por: Tassone, Annalisa, et al.
Publicado: (2023)

Neocortical morphometry in Huntington's disease: Indication of the coexistence of abnormal neurodevelopmental and neurodegenerative processes
por: Mangin, Jean-Francois, et al.
Publicado: (2020)

Prion‐like mechanisms in neurodegenerative disease: Implications for Huntington's disease therapy
por: Srinageshwar, Bhairavi, et al.
Publicado: (2020)

Translating cell therapies for neurodegenerative diseases: Huntington’s disease as a model disorder
por: Rosser, Anne E., et al.
Publicado: (2022)

Quantitative connection between polyglutamine aggregation kinetics and neurodegenerative process in patients with Huntington’s disease
por: Sugaya, Keizo, et al.
Publicado: (2012)

Crosstalk between the Hippo Pathway and the Wnt Pathway in Huntington’s Disease and Other Neurodegenerative Disorders
por: Sileo, Pasquale, et al.
Publicado: (2022)

Neuro-Cardio Mechanisms in Huntington’s Disease and Other Neurodegenerative Disorders
por: Critchley, Bethan J., et al.
Publicado: (2018)

Mitochondrial Quality Control in Neurodegenerative Diseases: Focus on Parkinson's Disease and Huntington's Disease
por: Franco-Iborra, Sandra, et al.
Publicado: (2018)

Transgenic Rat Model of Huntington's Disease: A Histopathological Study and Correlations with Neurodegenerative Process in the Brain of HD Patients
por: Mazurová, Yvona, et al.
Publicado: (2014)

Unraveling Molecular and Genetic Insights into Neurodegenerative Diseases: Advances in Understanding Alzheimer’s, Parkinson’s, and Huntington’s Diseases and Amyotrophic Lateral Sclerosis
por: Ciurea, Alexandru Vlad, et al.
Publicado: (2023)

Evidence for a Pan-Neurodegenerative Disease Response in Huntington's and Parkinson's Disease Expression Profiles
por: Labadorf, Adam, et al.
Publicado: (2018)

Error Processing in Huntington's Disease
por: Beste, Christian, et al.
Publicado: (2006)

Adenyl cyclase activator forskolin protects against Huntington's disease-like neurodegenerative disorders
por: Mehan, Sidharth, et al.
Publicado: (2017)

Conclusions of the SIGNAL study in Huntington and implications for treatment of other slowly progressive neurodegenerative diseases
por: Zauderer, Maurice, et al.
Publicado: (2023)

Effects of gut microbiota on neurodegenerative diseases
por: Khatoon, Saima, et al.
Publicado: (2023)

A Fresh Look at Huntingtin mRNA Processing in Huntington’s Disease
por: Romo, Lindsay, et al.
Publicado: (2018)

Irritability in Huntington’s Disease
por: Karagas, Nicholas E., et al.
Publicado: (2020)

COX-2 in the neurodegenerative process of Parkinson's disease
por: Teismann, Peter
Publicado: (2012)

The histone variant H3.3 claims its place in the crowded scene of epigenetics
por: Bano, Daniele, et al.
Publicado: (2017)

Huntington's disease: the case for genetic modifiers
por: Gusella, James F, et al.
Publicado: (2009)

Impaired mitochondrial respiration promotes dendritic branching via the AMPK signaling pathway
por: Gioran, A, et al.
Publicado: (2014)

Huntington Disease in Asia
por: Xu, Miao, et al.
Publicado: (2015)

SUMO-modifying Huntington’s disease
por: Soares, Ericks S., et al.
Publicado: (2022)

Biological aging processes underlying cognitive decline and neurodegenerative disease
por: Gonzales, Mitzi M., et al.
Publicado: (2022)

Therapeutic Strategies in Huntington's Disease
por: Kanazawa, Ichiro
Publicado: (2006)

Neuropsychiatric Burden in Huntington’s Disease
por: Paoli, Ricardo Augusto, et al.
Publicado: (2017)

PET Imaging in Huntington’s Disease
por: Roussakis, Andreas-Antonios, et al.
Publicado: (2015)

The Neurodevelopmental Hypothesis of Huntington’s Disease
por: van der Plas, Ellen, et al.
Publicado: (2020)

Therapeutic Advances for Huntington’s Disease
por: Kumar, Ashok, et al.
Publicado: (2020)

DNA Methylation in Huntington’s Disease
por: Zsindely, Nóra, et al.
Publicado: (2021)

Olfactory Dysfunction in Huntington’s Disease
por: Patino, Jorge, et al.
Publicado: (2021)

Recent approaches on Huntington's disease (Review)
por: Palaiogeorgou, Anastasia Marina, et al.
Publicado: (2022)

Huntington’s Disease Pathogenesis: Two Sequential Components
por: Hong, Eun Pyo, et al.
Publicado: (2021)

Huntington's Disease: An Immune Perspective
por: Nayak, Annapurna, et al.
Publicado: (2011)

Plants and phytochemicals for Huntington's disease
por: Choudhary, Sunayna, et al.
Publicado: (2013)

Revisiting the neuropsychiatry of Huntington's disease
por: Teixeira, Antonio Lucio, et al.
Publicado: (2016)

Mitochondrial Dynamics in Neurodegenerative Diseases: Unraveling the Role of Fusion and Fission Processes
por: Grel, Hubert, et al.
Publicado: (2023)

Recent Microscopy Advances and the Applications to Huntington’s Disease Research
por: Babi, Mouhanad, et al.
Publicado: (2022)

Therapeutic Advances in the Management of Huntington’s Disease
por: Abdulrahman, Ganiy Opeyemi
Publicado: (2011)

Management of Huntington’s disease: role of tetrabenazine
por: de Tommaso, Marina, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_17uk65ai3ul6cd8suqh3mqeikk